Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
18 oct. 2021 16h50 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on...
Harvard Bioscience Announces Second Quarter 2021 Financial Results
05 août 2021 07h00 HE
|
Harvard Bioscience, Inc.
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 25% year-over-year as sales momentum continuesCellular and Molecular (CMT) product...
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
19 juil. 2021 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on...
Harvard Bioscience Announces First Quarter 2021 Financial Results
06 mai 2021 07h15 HE
|
Harvard Bioscience, Inc.
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins Revenue up 14% as sales momentum from Q4’20 continuesPre-clinical product...
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
19 avr. 2021 16h55 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May...
Harvard Bioscience Announces Fourth Quarter 2020 Financial Results
10 mars 2021 07h00 HE
|
Harvard Bioscience, Inc.
Revenue returns to pre-Covid19 levels on strong CRO/pharma salesOperating margin increased year-over-year on GAAP and an adjusted basisNew debt facility significantly reduces annual interest expense ...
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
18 févr. 2021 17h24 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on...
Harvard Bioscience Announces New Credit Facility
22 déc. 2020 18h05 HE
|
Harvard Bioscience, Inc.
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platform HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) --...
Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference
16 nov. 2020 16h35 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in...
Harvard Bioscience Announces Third Quarter 2020 Financial Results
05 nov. 2020 07h00 HE
|
Harvard Bioscience, Inc.
Operating margin up year-over-year on GAAP and adjusted basisRevenue improved sequentially with solid CRO/pharma demand and academic labs reopeningGenerated positive operating cash flow in Q3 with...